한글목차

세계 재조합 DNA 기술 시장 규모는 2025년 1,899억 1,000만 달러로 추정되며, 2032년에는 3,656억 2,000만 달러에 달할 것으로 예상되며, 2025-2032년 연평균 9.8%로 성장할 것으로 예상됩니다.

그림. 재조합 DNA 기술 시장 점유율(%), 2025년, 지역별

재조합 DNA 기술은 두 개의 서로 다른 출처의 DNA 분자를 결합하여 자신의 구성요소와 관련 단백질의 복제 및 조립을 지시할 수 있는 하나의 분자로 만드는 것입니다. 이 과정은 제한효소, DNA 리가제, 역전사효소를 사용하여 두 개의 서로 다른 DNA 가닥을 물리적으로 결합하고 엮는 것을 포함합니다. 최근 재조합 DNA 기술은 유전학 및 생명공학 분야에서 혁명적인 발전을 이루었으며, 의약품 개발, 연구, 농업 등 다양한 분야에 적용되고 있음이 입증되고 있습니다. 이 기술을 통해 기존 추출법보다 훨씬 더 많은 양의 인간 단백질과 의약품을 생산할 수 있게 되었습니다. 또한, 현재 불치병의 새로운 치료법 개발 및 농작물 수확량 향상에도 활용되고 있습니다. 산업계 전반의 수요 증가로 인해 재조합 DNA 기술 시장은 향후 몇 년 동안 크게 성장할 것으로 예상됩니다.

시장 역학:

재조합 DNA 기술 시장은 제약 및 생명공학 산업의 R&D 활동 증가, 만성질환의 유병률 증가, 유전공학 및 유전자 치료에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 또한, 저렴한 의료 및 치료 솔루션에 대한 수요와 DNA 분석 및 시퀀싱 기술의 기술적 진보가 결합하여 시장 성장을 촉진하고 있습니다. 그러나 개발에 따른 높은 비용과 임상시험에 대한 엄격한 규제는 시장 성장을 제한할 수 있습니다. 또한, 생식세포 계열 유전자 편집에 대한 윤리적 문제는 시장 확대에 걸림돌이 될 수 있습니다. 반면, 신흥국의 의료비 지출 증가는 주요 기업들에게 유리한 기회를 제공합니다. 또한, 농업용 유전자 변형 작물의 수용성 확대는 향후 몇 년 동안 새로운 수익원을 창출할 것으로 예상됩니다.

본 조사의 주요 특징

• 세계의 재조합 DNA 기술 시장을 상세히 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 CAGR(연평균 성장률)에 대해 조사 분석하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
• 본 보고서에서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 재조합 DNA 기술 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 재조합 DNA 기술 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 재조합 DNA 기술 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 최근 동향
• 규제 시나리오
• 기술의 진보
• 제조업체 매출
• 인수와 제휴 시나리오
• 제품 발매/승인
• 자금 조달과 투자
• PEST 분석
• Porters 분석

제4장 세계의 재조합 DNA 기술 시장 : COVID-19 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• COVID-19의 시장에 대한 영향

제5장 세계의 재조합 DNA 기술 시장 : 제품 유형별(2020-2032년)

• 재조합 단백질 의약품
• 백신
• 유전자 재조합 작물
• 세포 및 유전자 치료
• 유전자 편집

제6장 세계의 재조합 DNA 기술 시장 : 용도별(2020-2032년)

• 치료
• 농업
• 연구
• 기타

제7장 세계의 재조합 DNA 기술 시장 : 최종사용자별(2020-2032년)

• 바이오테크놀러지 및 제약회사
• 진단 검사실
• 학술기관 및 정부기관 연구소
• 기타

제8장 세계의 재조합 DNA 기술 시장 : 지역별(2020-2032년)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Thermo Fisher Scientific, Inc.
  • Biogen, Inc.
  • Sanofi
  • Pfizer, Inc.
  • Amgen, Inc.
  • Merck &Co., Inc.
  • Profacgen
  • Monsanto Company
  • Genentech Inc.
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • GSK plc.
  • Jiangsu Recbio Technology Co., Ltd.
  • New England Biolabs
  • GenScript
  • Lonza
  • ProteoGenix

제10장 애널리스트의 견해

• Wheel of Fortune
• 애널리스트의 견해
• Coherent Opportunity Map(COM)

제11장 참고문헌과 조사 방법

• 참고문헌
• 조사 방법

영문목차

Global Recombinant Dna Technology Market is estimated to be valued at USD 189.91 Bn in 2025 and is expected to reach USD 365.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.

Figure. Recombinant Dna Technology Market Share (%), By Region 2025

Recombinant DNA technology is the joining together of DNA molecules from two different sources into one molecule that can replicate and direct the assembly of its own components or related proteins. This process involves physically combining and interweaving two different strands of DNA through the use of restriction enzymes, DNA ligases and reverse transcriptase. In recent years, recombinant DNA technology has proven to be a revolutionary advancement in the field of genetics and biotechnology with wide ranging applications in drug development, research, and agriculture. This technology allows for the production of human proteins and medicines in much larger quantities than traditional extraction methods. It is also being used to develop new treatments for currently incurable diseases and to enhance crop yields. With growing demand across industries, the recombinant DNA technology market is poised to grow significantly in the coming years.

Market Dynamics:

The recombinant DNA technology market is driven by several factors such as increasing R&D activities in pharmaceutical and biotech industries, rising prevalence of chronic diseases, growing demand for genetic engineering, and gene therapy. The demand for affordable healthcare and therapeutic solutions combined with technological advancements in DNA analysis and sequencing techniques are also fueling the market growth. However, the market growth can be restricted due to high costs associated with development and stringent regulations for clinical trials. Moreover, ethical issues regarding germline gene editing may hamper market expansion to some extent. On the flip side, rising healthcare expenditures in emerging nations offer lucrative opportunities for key players. In addition, the growing acceptance of genetically modified crops for agriculture applications is expected to create new revenue pockets in the forthcoming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global recombinant DNA technology market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global recombinant DNA technology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi , Pfizer, Inc., Amgen, Inc., Merck & Co., Inc., Profacgen, Monsanto Company, Genentech Inc., Eli Lilly and Company, Janssen Pharmaceuticals Inc., GSK plc., Jiangsu Recbio Technology Co., Ltd., New England Biolabs, GenScript, Lonza, and ProteoGenix.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global recombinant DNA technology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant DNA technology market.

Detailed Segmentation-

• By Product Type:
  • Recombinant Protein Drugs
  • Vaccines
  • Genetically Modified Crops
  • Cell and Gene Therapy
  • Gene Editing
• By Application:
  • Therapeutics
  • Agriculture
  • Research
  • Others
• By End User:
  • Biotechnology and Pharmaceutical Company
  • Diagnostic Laboratories
  • Academic and Government Laboratories
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific, Inc.
  • Biogen, Inc.
  • Sanofi
  • Pfizer, Inc.
  • Amgen, Inc.
  • Merck & Co., Inc.
  • Profacgen
  • Monsanto Company
  • Genentech Inc.
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • GSK plc.
  • Jiangsu Recbio Technology Co., Ltd.
  • New England Biolabs
  • GenScript
  • Lonza
  • ProteoGenix

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Regulatory Scenario
• Technological Advancements
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Recombinant DNA Technology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Recombinant DNA Technology Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Recombinant Protein Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetically Modified Crops
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell and Gene Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gene Editing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Recombinant DNA Technology Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Therapeutics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Agriculture
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Recombinant DNA Technology Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Biotechnology and Pharmaceutical Company
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Government Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Recombinant DNA Technology Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Biogen, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Amgen, Inc.
  • Merck & Co., Inc.
  • Profacgen
  • Monsanto Company
  • Genentech Inc.
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • GSK plc.
  • Jiangsu Recbio Technology Co., Ltd.
  • New England Biolabs
  • GenScript
  • Lonza
  • ProteoGenix

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"